Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06307886

Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator

Comparison of five-year survival and disease-free survival in patients diagnosed with endometrium cancer who underwent total laparoscopic hysterectomy with and without a uterine manipulator

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Endometrial Cancer Endometrial Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Diseases Uterine Neoplasms

Age range

18 year–75 year

Sex eligibility

Female

Study type

Observational

Primary location

Gaziosmanpasa Training and research hospital

Istanbul, Turkey (Türkiye)

Location status: Recruiting

Location contact

Fatma Ketenci Gencer, Associate Professor

SUB_INVESTIGATOR

Havva Betül Bacak, Specialist

CONTACT

[email protected]

+905333610088

Süleyman Salman, Professor

CONTACT

[email protected]

+905059345470

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients suitable for laparoscopic surgery patients ages 18-75 patients diagnosed figo stage 1 and 2 endometrial cancer

Exclusion criteria

  • patients not suitable for laparoscopic surgery patients diagnosed figo stage 3 and 4 endometrial cancer pregnant patients

Treatment and study plan

Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulator

Procedure

patients who underwent laparoscopic hysterectomy with using uterine manipulator

lPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulator

Procedure

patients who underwent laparoscopic hysterectomy without using uterine manipulator

Primary outcomes

  1. five year survival in patients diagnosed with endometrial cancer

    Time frame: 5 year

  2. disease-free survival in patients diagnosed with endometrial cancer

    Time frame: 5 year

Study contacts

Contact information is provided by the study sponsor or research team.

Süleyman Salman, Professor

CONTACT

[email protected]

+905059345470

havva betül bacak, Specialist

CONTACT

[email protected]

+905333610088

Sponsors and collaborators

Lead sponsor

Gaziosmanpasa Research and Education Hospital

Other Gov

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2028
First posted
Mar 13, 2024
Registry last updated
Jan 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.